High Glucose Levels Promote Switch to Synthetic Vascular Smooth Muscle Cells via Lactate/GPR81.
Jing YangGlenn R GourleyAdam GilbertsenChi ChenLei WangKaren SmithMarion NamenwirthLibang YangPublished in: Cells (2024)
Hyperglycemia, lipotoxicity, and insulin resistance are known to increase the secretion of extracellular matrix from cardiac fibroblasts as well as the activation of paracrine signaling from cardiomyocytes, immune cells, and vascular cells, which release fibroblast-activating mediators. However, their influences on vascular smooth muscle cells (vSMCs) have not been well examined. This study aimed to investigate whether contractile vascular vSMCs could develop a more synthetic phenotype in response to hyperglycemia. The results showed that contractile and synthetic vSMCs consumed high glucose in different ways. Lactate/GPR81 promotes the synthetic phenotype in vSMCs in response to high glucose levels. The stimulation of high glucose was associated with a significant increase in fibroblast-like features: synthetic vSMC marker expression, collagen 1 production, proliferation, and migration. GPR81 expression is higher in blood vessels in diabetic patients and in the high-glucose, high-lipid diet mouse. The results demonstrate that vSMCs assume a more synthetic phenotype when cultured in the presence of high glucose and, consequently, that the high glucose could trigger a vSMC-dependent cardiovascular disease mechanism in diabetes via lactate/GPR81.
Keyphrases
- high glucose
- vascular smooth muscle cells
- endothelial cells
- angiotensin ii
- extracellular matrix
- cardiovascular disease
- fatty acid
- type diabetes
- insulin resistance
- poor prognosis
- skeletal muscle
- induced apoptosis
- weight loss
- metabolic syndrome
- heart failure
- adipose tissue
- left ventricular
- coronary artery disease
- binding protein
- cardiovascular events
- smooth muscle
- atrial fibrillation
- endoplasmic reticulum stress